Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 151 AL 165

Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein

Santosa C, Rasche S, Barakat A, Bellingham SA, Ho M, Tan J, Hill AF, Masters CL, McLean C, Evin G.

Neurobiol Dis. 2011 Jul;43(1):176-83. doi: 10.1016/j.nbd.2011.03.009. Epub 2011 Apr 3.

Parallel findings in age-related macular degeneration and Alzheimer's disease

Ohno-Matsui K.

Prog Retin Eye Res. 2011 Jul;30(4):217-38. doi: 10.1016/j.preteyeres.2011.02.004. Epub 2011 Mar 25.

Targeting the kynurenine pathway-related alterations in Alzheimer's disease: a future therapeutic strategy

Plangár I, Zádori D, Klivényi P, Toldi J, Vécsei L.

J Alzheimers Dis. 2011;24 Suppl 2:199-209. doi: 10.3233/JAD-2011-110131.

Monocytes and Alzheimer's disease

Feng Y, Li L, Sun XH.

Neurosci Bull. 2011 Apr;27(2):115-22. doi: 10.1007/s12264-011-1205-3.

State of aggregation

Nat Neurosci. 2011 Apr;14(4):399. doi: 10.1038/nn0411-399.

Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease

Santos RX, Correia SC, Cardoso S, Carvalho C, Santos MS, Moreira PI.

J Neurochem. 2011 Jun;117(6):927-36. doi: 10.1111/j.1471-4159.2011.07262.x. Epub 2011 May 3.

Touch Panel-type Dementia Assessment Scale: a new computer-based rating scale for Alzheimer's disease

Inoue M, Jimbo D, Taniguchi M, Urakami K.

Psychogeriatrics. 2011 Mar;11(1):28-33. doi: 10.1111/j.1479-8301.2010.00345.x. Epub 2011 Feb 25.

Linking lipids to Alzheimer's disease: cholesterol and beyond

Di Paolo G, Kim TW.

Nat Rev Neurosci. 2011 May;12(5):284-96. doi: 10.1038/nrn3012. Epub 2011 Mar 30.

Amyloid precursor protein processing and Alzheimer's disease

O'Brien RJ, Wong PC.

Annu Rev Neurosci. 2011;34:185-204. doi: 10.1146/annurev-neuro-061010-113613.

Membrane anchored and lipid raft targeted β-secretase inhibitors for Alzheimer's disease therapy

Ben Halima S, Rajendran L.

J Alzheimers Dis. 2011;24 Suppl 2:143-52. doi: 10.3233/JAD-2011-110269.

Memantine in moderate to severe Alzheimer's disease: an observational post-marketing study

Rainer M, Wuschitz A, Jagsch C, Erb C, Chirikdjian JJ, Mucke HA.

J Neural Transm (Vienna). 2011 Aug;118(8):1255-9. doi: 10.1007/s00702-011-0623-8. Epub 2011 Apr 2.

Public financial support receipt and non-medical resource utilization in Alzheimer's disease results from the PLASA study

Rapp T, Grand A, Cantet C, Andrieu S, Coley N, Portet F, Vellas B.

Soc Sci Med. 2011 Apr;72(8):1310-6. doi: 10.1016/j.socscimed.2011.02.039. Epub 2011 Mar 21.

Lipid metabolism and glial lipoproteins in the central nervous system

Hayashi H.

Biol Pharm Bull. 2011;34(4):453-61. doi: 10.1248/bpb.34.453.

Neurovascular function in Alzheimer's disease patients and experimental models

Nicolakakis N, Hamel E.

J Cereb Blood Flow Metab. 2011 Jun;31(6):1354-70. doi: 10.1038/jcbfm.2011.43. Epub 2011 Apr 6.

Rapid eye movement sleep atonia in patients with cognitive impairment

Chen PC, Wu D, Chen CC, Chi NF, Kang JH, Hu CJ.

J Neurol Sci. 2011 Jun 15;305(1-2):34-7. doi: 10.1016/j.jns.2011.03.022. Epub 2011 Apr 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias